These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 16718812)

  • 1. Immune therapy including dendritic cell based therapy in chronic hepatitis B virus infection.
    Akbar SM; Horiike N; Onji M
    World J Gastroenterol; 2006 May; 12(18):2876-83. PubMed ID: 16718812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine therapy for hepatitis B virus carrier.
    Akbar SM; Furukawa S; Horiike N; Onji M
    Curr Drug Targets Infect Disord; 2004 Jun; 4(2):93-101. PubMed ID: 15180457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic cells and chronic hepatitis virus carriers.
    Akbar SM; Horiike N; Onji M; Hino O
    Intervirology; 2001; 44(4):199-208. PubMed ID: 11509880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent Mechanism.
    van Montfoort N; van der Aa E; van den Bosch A; Brouwers H; Vanwolleghem T; Janssen HLA; Javanbakht H; Buschow SI; Woltman AM
    J Virol; 2016 Jul; 90(14):6187-6199. PubMed ID: 27099316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunopathogenesis of Hepatitis B Virus.
    Tseng TC; Huang LR
    J Infect Dis; 2017 Nov; 216(suppl_8):S765-S770. PubMed ID: 29156047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy of chronic hepatitis B by anti HBV vaccine.
    Pol S; Couillin I; Michel ML; Driss F; Nalpas B; Carnot F; Berthelot P; Bréchot C
    Acta Gastroenterol Belg; 1998; 61(2):228-33. PubMed ID: 9658616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody-mediated immunotherapy against chronic hepatitis B virus infection.
    Gao Y; Zhang TY; Yuan Q; Xia NS
    Hum Vaccin Immunother; 2017 Aug; 13(8):1768-1773. PubMed ID: 28521640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-antigen-specific and antigen-specific immune therapies for chronic hepatitis B: evidences from laboratory benches and patient's bedsides.
    Akbar SM; Al-Mahtab M; Khan MS
    Expert Opin Biol Ther; 2013 Jul; 13(7):1063-74. PubMed ID: 23581572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of HBV-pulsed DCs in combination with entecavir in patients with chronic hepatitis B infection.
    Wei MJ; Pan XN; Wei KP; Li XH; Liu XL; Zhang XM; Jiang YL; Zhang CY; Shen JK
    Int Immunopharmacol; 2015 Aug; 27(2):238-43. PubMed ID: 26118632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune balance in Hepatitis B Infection: Present and Future Therapies.
    Vyas AK; Jindal A; Hissar S; Ramakrishna G; Trehanpati N
    Scand J Immunol; 2017 Jul; 86(1):4-14. PubMed ID: 28387980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in therapeutics for chronic hepatitis B.
    Yang N; Bertoletti A
    Hepatol Int; 2016 Mar; 10(2):277-85. PubMed ID: 26363922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
    Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
    Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the hepatitis B virus S‑ecdCD40L vaccine therapy in HBV transgenic mice: A vaccine‑induced activation of antigen presenting dendritic cells.
    Guan H; Lan S; Wu J; Tang B; Xu Y
    Mol Med Rep; 2017 Nov; 16(5):6102-6108. PubMed ID: 28849136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer.
    Akbar SM; Furukawa S; Hasebe A; Horiike N; Michitaka K; Onji M
    Int J Mol Med; 2004 Aug; 14(2):295-9. PubMed ID: 15254781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy for Chronic Hepatitis B Virus Infection.
    Bertoletti A; Le Bert N
    Gut Liver; 2018 Sep; 12(5):497-507. PubMed ID: 29316747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. China's efforts to shed its title of "Leader in liver disease".
    Li X; Xu WF
    Drug Discov Ther; 2007 Oct; 1(2):84-5. PubMed ID: 22504391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy with antiviral drugs and hepatitis B vaccine in incidentally-detected and asymptomatic chronic hepatitis virus B carriers at Bangladesh.
    Al-Mahtab M; Rahman S; Akbar SM; Khan SI; Uddin H; Karim F; Ahmed F
    Viral Immunol; 2010 Jun; 23(3):335-8. PubMed ID: 20565297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic hepatitis B: Immunological profile and current therapeutic vaccines in clinical trials.
    Lobaina Y; Michel ML
    Vaccine; 2017 Apr; 35(18):2308-2314. PubMed ID: 28351734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward a Cure for Hepatitis B Virus Infection: Combination Therapy Involving Viral Suppression and Immune Modulation and Long-term Outcome.
    Wu D; Ning Q
    J Infect Dis; 2017 Nov; 216(suppl_8):S771-S777. PubMed ID: 29156046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapeutic interventions in chronic hepatitis B virus infection: a review.
    Wang L; Zou ZQ; Liu CX; Liu XZ
    J Immunol Methods; 2014 May; 407():1-8. PubMed ID: 24747918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.